Methylprednisolone
Synonyms / Brand Names:Methyleneprednisolone, Methylprednisolon, Methylprednisolonum, Metilprednisolona, Metilprednisolone, 6alpha-Methylprednisolone, Artisone-Wyeth, Besonia, Dopomedrol, Esametone, Firmacort, Lemod, Medesone, Medixon, Medlone 21, Medrate, Medrol Adt Pak, Medrol Dosepak, Medrone, Mesopren, Metastab, Metilbetasone, Metrisone, Metrocort, Metysolon, Moderin, Nirypan, Noretona, Predni N Tablinen, Promacortine, Reactenol, Sieropresol, Solomet, Summicort, Suprametil, Urbason, Urbasone, Wyacort
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosing and Administration
The initial dosage of Methylprednisolone Tablets may vary from 4 mg to 48 mg of Methylprednisolone per day depending on the specific disease entity being treated. In situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory clinical response, Methylprednisolone Tablets should be discontinued and the patient transferred to other appropriate therapy.
IT SHOULD BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE UNDER TREATMENT AND THE RESPONSE OF THE PATIENT
For more information on dosing pleaser refer to Instructions for administration
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Methylprednisolone
Return to top
Publication Resources
Most Recent Articles on Methylprednisolone
Review Articles on Methylprednisolone
Articles on Methylprednisolone in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Methylprednisolone
Return to top
Trial Resources
Ongoing Trials with Methylprednisolone at Clinical Trials.gov
Trial Results with Methylprednisolone
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Methylprednisolone
Cochrane Collaboration on Methylprednisolone
Cost Effectiveness of Methylprednisolone
Return to top
Media Resources
Powerpoint Slides on Methylprednisolone
Images of Methylprednisolone
Podcasts & MP3s on Methylprednisolone
Videos on Methylprednisolone
Return to top
Patient Resources
Patient Resources on Methylprednisolone
Discussion Groups on Methylprednisolone
Patient Handouts on Methylprednisolone
Blogs on Methylprednisolone
Methylprednisolone in the News
Methylprednisolone in the Marketplace
Return to top
International Resources
Methylprednisolone en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies